SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001319244-19-000080
Filing Date
2019-10-22
Accepted
2019-10-22 17:13:27
Documents
1
Group Members
ICS OPPORTUNITIES II LLCINTEGRATED ASSETS II LLCINTEGRATED CORE STRATEGIES (US) LLCISRAEL A. ENGLANDERMILLENNIUM GROUP MANAGEMENT LLCMILLENNIUM INTERNATIONAL MANAGEMENT LPMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 DCPH_SC13G_Oct2019.htm SC 13G 141880
  Complete submission text file 0001319244-19-000080.txt   143936
Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103
Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103 (212) 841-4100
INTEGRATED CORE STRATEGIES (US) LLC (Filed by) CIK: 0001319244 (see all company filings)

IRS No.: 202196675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Subject) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90130 | Film No.: 191162262
SIC: 2834 Pharmaceutical Preparations